PBM not in “Best Interests” of City

October 16, 2013 – An audit by the City of Houston Controller’s Office concludes that the City lost millions of dollars in its self-insured prescription medication program.

For municipalities, as for any other self-funded company, there are often hidden costs to doing business with a PBM. The City of Houston’s agreement with CIGNA, for instance, allowed the company to charge the City one price for any given medication, but then to remit less to the pharmacy. CIGNA kept the difference. These so-called “spreads” cost the city’s plan participants $3.7 million in potential rebates.

“Our audit indicates that the City should… not rely solely on the plan administrator – CIGNA – to make decisions that should inherently benefit the City,” said Houston City Controller Ronald Green. “In the agreement with CIGNA, the average wholesale price and the qualification or preferences of generic and brand drugs were not in the best interests of the City.”

The Controller’s audit reviewed approximately 517,497 claims from the first year of a three-year agreement between the parties. The plan’s cost of drugs was $10.4 million, compared to the market average wholesale price of $8.4 million. As always, the devil was in the details, the contract allowed CIGNA to apply “positive margin” pricing, something not typical in a large PBM agreement.

Additionally, the Controller noted, “In the contract, CIGNA is permitted to choose the preferred drug based on the rebate, not on the efficacy-effectiveness of the drug nor the cost/benefit ratio of the medication. Clearly, the City should have significant input into the formulary offered to its employees and their dependents, and it appears we did not have that input.”

Read the full press release here:

“Controller says pharmacy benefits not in ‘best interests’ of City and employees”


40 Grove St, Suite 270 Wellesley, MA 02482

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle


© Copyright 2020 Scripta Insights, Inc. 

Scripta™ is neither a pharmacy nor a doctor. The benefit service does not tell you what drug to take and does not participate in the drug selection process. Only your physician can determine the medications that are right for you. These alternative medications are options for less costly drugs that physicians may prescribe in place of the medications you are taking now. Scripta has reviewed your current medications only for the purpose of identifying potential cost savings for you to consider with your physician. Scripta has not analyzed the effectiveness or other therapeutic aspects of these medication alternatives. Accordingly, this report and any other forms of communication received from Scripta are not, nor should they be interpreted as, any form of treatment, drug regimen review, or provision of counseling or consultation by a prescriber, pharmacist or pharmacy. Do not stop taking your medication, change your medication, or start taking a new medication without being directed to do so by your physician and filling the prescription under the oversight of a licensed pharmacist. The alternatives set forth above may not be equivalent to your current medication, may interact adversely with your other medications, may not be indicated in light of your other conditions, may cause different or severe side effects, or may be less effective at treating your condition. Medication prices are approximate based on information provided by your pharmacy benefits manager, insurance plans, and/or employer, and may vary from pharmacy to pharmacy. Check with your insurance plan to obtain a full list of pharmacies where your prescriptions can be filled. All information herein is HIPAA protected, treated as highly confidential, and never shared with your employer.

Scripta™, Scripta Insights™ and The Best Meds at the Best Price® are registered trademarks of Scripta Insights, Inc. The contents of the site are for informational purposes only and not intended as a substitute for professional medical advice, diagnosis, or treatment. We do not recommend or endorse any specific prescription drug or pharmacy that may be mentioned herein. Reliance on any information provided by us, our affiliates, employees or others is solely at your own risk.